Skip to main content
Caplight Logo









Multiply Labs

Multiply Labs

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://multiplylabs.com

Last Round

Series B

Oct 6, 2026

Est. Valuation

$60M

Total Funding Raised

$108.92M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Multiply Labs operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series B round in October 2026.

Multiply Labs is a biotechnology company that develops cloud-controlled, modular robotic systems to automate the manufacturing of personalized medicines and advanced therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Industrial Robotics, Biotechnology, Workflow Automation

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Multiply Labs Comparables

Compare Multiply Labs with similar companies based on industry and business-model similarity.

Multiply Labs comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellular Origins
89%
Ori Biotech
88%
Adva Biotechnology
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Multiply Labs Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 6, 2026
Series A ExtensionApr 10, 2023
Series AApr 14, 2021
SeedMay 2, 2017
AcceleratorAug 20, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Fred Parietti

Co-Founder And CEO

Founding Team

For institutional investors. Book with your work email.

Multiply Labs Investors

Notable investors and investment history

Multiply Labs investors
InvestorRounds
Strange VenturesSeries B
LingottoSeries B
NantWorksSeries B
Founders FundSeries A, Series B
Lux CapitalSeries A, Series B
Teradyne Robotics VenturesSeries B
Garage CapitalSeries A
Book a demo to see all 19 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 6, 2026

    $75M round led by NantWorks.

  • Jul 29, 2026

    Grew 18% QoQ, from 67 to 79 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_financingOct 6, 2026

    On Oct 6th '26 in California, Multiply Labs raises $75M in a Series B led by Dr. Patrick Soon-Shiong with NantWorks, with participation from AstraZeneca, Lingotto, Teradyne, Strange Ventures, and returning investors, to scale its robotic drug-manufacturing platform.

Book a demo to see all news

For institutional investors. Book with your work email.

Multiply Labs Filings

Explore SEC and related filing metadata, where available.

Multiply Labs filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Multiply Labs's valuation, stock price, and market status.

Is Multiply Labs a public or private company?

Multiply Labs is a private company.

What is the current stock price of Multiply Labs?

Multiply Labs is a private company, so its shares have no public market price. Caplight tracks Multiply Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Multiply Labs worth (valuation)?

Multiply Labs's valuation is estimated at $60.0M based on funding round data.

Can I buy Multiply Labs stock?

Multiply Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Multiply Labs's last funding round?

Multiply Labs's most recent funding round was Series B on October 6, 2026.

Who are the main investors in Multiply Labs?

Key investors in Multiply Labs include NantWorks, Y Combinator, Casdin Capital, P101.

Will Multiply Labs IPO soon?

No public IPO plans have been announced for Multiply Labs.

How can I track Multiply Labs secondary market activity?

Caplight tracks bids, offers, and trades in Multiply Labs's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range67
Year Founded2016
Last FundingOct 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?